You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Glycated Hemoglobin A1c

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Type 2 Trial in Bogotá (Point of Care - Glycated Hemoglobin (A1c), Oral Glucose Tolerance Test)

Recruiting
  • Diabetes Mellitus, Type 2
  • Point of Care - Glycated Hemoglobin (A1c)
  • Oral Glucose Tolerance Test
  • Bogotá, Colombia
    Maria Granados
Jul 5, 2022

Blood Markers of Early Pancreas Cancer

Recruiting
  • Diabetes Mellitus, Type 2
  • +5 more
  • Mixed Meal Tolerance Test
  • +2 more
  • Omaha, Nebraska
    Nebraska Medical Center
Jan 31, 2022

Diabetes Trial in Cairo (1,5 Anhydroglucitol and 1,5 Anhydroglucitol / Glycated Hemoglobin ratio)

Recruiting
  • Diabetes Mellitus
  • 1,5 Anhydroglucitol and 1,5 Anhydroglucitol / Glycated Hemoglobin ratio
  • Cairo, Manial, Egypt
    Cairo University
Mar 22, 2022

Width and HbA1C in Type 2 Diabetes Mellitus After Glycemic

Not yet recruiting
  • Type 2 Diabetes
  • Glycated hemoglobin (HbA1C)
  • +2 more
  • (no location specified)
Sep 28, 2023

Pre-diabetes Trial in Norwich (Broccoli soup, Courgette soup)

Enrolling by invitation
  • Pre-diabetes
  • Broccoli soup
  • Courgette soup
  • Norwich, United Kingdom
    Quadram Institute Bioscience
May 4, 2022

Trajectories of Fatigue and Quality of Life in People With Both

Not yet recruiting
  • Pancreatic Cancer Resectable
  • Diabetes Mellitus
    • (no location specified)
    Aug 22, 2023

    Hemoglobin A1c and Acute Kindey Injury After Coronary Artery

    Completed
    • Acute Kidney Injury
    • increase in serum creatinine
    • Cairo, Egypt
      Ain-Shams University
    May 22, 2022

    Glucose Intolerance, Glucose Metabolism Disorders (Including Diabetes) Trial in West Lafayette (Almond, Control)

    Recruiting
    • Glucose Intolerance
    • Glucose Metabolism Disorders (Including Diabetes Mellitus)
    • Almond
    • Control
    • West Lafayette, Indiana
      Purdue Univeristy
    Apr 18, 2022

    Diabetes Type 2 Trial in Doha (Metformin, Gliclazide, Sitagliptin)

    Active, not recruiting
    • Diabetes Mellitus Type 2
    • Doha, Qatar
      Hamad Medical Corporation
    Apr 27, 2022

    Recurrent Cardiovascular Events in Type 2 Diabetes After PCI

    Recruiting
    • Diabetes Mellitus
    • Percutaneous Coronary Intervention
      • Shanghai, China
        Department of Cardiology,Shanghai Tenth People's Hospital
      Nov 22, 2021

      Sickle Cell Disease Trial in Groningen (GBT021601)

      Active, not recruiting
      • Sickle Cell Disease
      • Groningen, Netherlands
        ICON Clinical Research Unit
      Jan 30, 2023

      Gait Performance in Diabetic Polyneuropathy Patients

      Recruiting
      • Diabetic Polyneuropathy
        • Giza, Egypt
          Faculty of physical therapy-Cairo University
        Jul 11, 2022

        A Study of Glycemic Control in Left Ventricular Assist

        Not yet recruiting
        • Type 2 Diabetes Mellitus
        • +2 more
        • Freestyle Libre 3 Continuous Glucose Monitor (CGM)
        • Rochester, Minnesota
          Mayo Clinic in Rochester
        Jun 28, 2023

        Type 2 Diabetes Trial in Jacksonville (Medically tailored meals)

        Completed
        • Type 2 Diabetes
        • Medically tailored meals
        • Jacksonville, Florida
        • +1 more
        Jul 9, 2021

        Optimal A1c Control in Post Liver or Combined Liver and Kidney

        Withdrawn
        • Diabetes
        • +2 more
        • hemoglobin A1c
        • Dallas, Texas
          Methodist Health System
        Sep 10, 2021

        Diabetes, Type 2 Trial (LIBERATE)

        Not yet recruiting
        • Diabetes Mellitus, Type 2
        • LIBERATE
        • (no location specified)
        Aug 11, 2022

        Diabetes, Type 2, Sleep Trial in East Lansing (Sleep education, Diet only)

        Completed
        • Diabetes Mellitus, Type 2
        • Sleep
        • Sleep education
        • Diet only
        • East Lansing, Michigan
          Michigan State University
        Dec 2, 2022

        HCL Insulin Delivery System on Glycemic Control in T1D

        Recruiting
        • Diabetes Mellitus, Type 1
        • Tandem t:slim X2 with hybrid closed loop system Control IQ, glucose sensor: Dexcom G6
        • MiniMed 780G, with hybrid closed loop system SmartGuard, sensor Guardien 4
        • Usti Nad Labem, Czechia
          Lucie Radovnická
        Jun 21, 2023

        Chronic Kidney Disease and Cardiovascular Disease Risk

        Withdrawn
        • Chronic Kidney Diseases
        • +2 more
        • Hemoglobin A1C
        • +2 more
        • (no location specified)
        Jul 12, 2022

        Diabetes With Periodontal Disease Trial in Pavia (Peribioma Toothpaste and Mousse, Standard toothpaste)

        Completed
        • Diabetes Mellitus With Periodontal Disease
        • Peribioma Toothpaste and Mousse
        • Standard toothpaste
        • Pavia, Lombardy, Italy
          Unit of Dental Hygiene - Section of Dentistry - Department of Cl
        Mar 13, 2022

        Hospitalized COVID-19 Patents At Assiut University Hospital

        Not yet recruiting
        • Diabetes Mellitus
        • COVID-19
        • Reverse transcription polymerase chain reaction (RT-PCR)
        • +4 more
        • (no location specified)
        Oct 16, 2021

        Electronic Triggers: Messaging After A1C EHR Alert

        Active, not recruiting
        • Hemoglobins
        • Diagnostic Tests
        • MyChart message
        • New York, New York
          NYU Langone Health
        Jan 26, 2023

        Stroke Trial in New Taipei City, Taipei city (Bifidobacterium longum OLP-01, Placebo)

        Active, not recruiting
        • Stroke
        • Bifidobacterium longum OLP-01
        • Placebo
        • New Taipei City, Taiwan
        • +2 more
        Jul 25, 2022

        Type 2 Diabetes Trial in Worldwide (Ertugliflozin 5 mg, Ertugliflozin 15 mg, Placebo)

        Recruiting
        • Type 2 Diabetes Mellitus
        • Ertugliflozin 5 mg
        • +4 more
        • Birmingham, Alabama
        • +99 more
        Nov 25, 2022

        Type 1 Diabetes Trial in Canada, United States (Insulin glargine, 300 units per milliliter (U/mL), Background therapy: Rapid

        Terminated
        Has Results
        • Type 1 Diabetes Mellitus
        • Insulin glargine, 300 units per milliliter (U/mL)
        • Background therapy: Rapid Acting meal time insulin analogs (Humalog, Novolog or Apidra)
        • West Des Moines, Iowa
        • +5 more
        Mar 24, 2022